Full Coverage

DUSA Files Form S-3 Shelf Registration Statement

marketwire.com
May 16, 2008
        
Story Timeline:  200 days

WILMINGTON, MASSACHUSETTS--(Marketwire - May 16, 2008) - DUSA Pharmaceuticals, Inc.(R) (NASDAQ GM:DUSA), a dermatology company that is developing and marketing Levulan(R) photodynamic therapy (PDT) and other products targeting patients with common skin conditions, today announced the filing of a... [read full story]                    

Add Comment
Latest article on this story:

DUSA Files Form S-3 Shelf Registration Statement (Marketwire)

 yahoo.com May 16, 2008
First article on this story:

DUSA Pharmaceuticals, Inc.: DUSA Files Form S-3 Shelf Registration Statement

 marketwire.com May 16, 2008
Selected publications with coverage of this story:
marketwire.com yahoo.com newsblaze.com
RELATED
Found 3 documents:

DUSA Files Form S-3 Shelf Registration Statement (Marketwire)

yahoo.com
May 16, 2008
        

WILMINGTON, MASSACHUSETTS--(MARKET WIRE)--May 16, 2008 -- DUSA Pharmaceuticals, Inc.® (NASDAQ GM: DUSA), a dermatology company that is developing and marketing Levulan® photodynamic therapy (PDT) and other products targeting patients with common skin conditions, today announced the filing of a...

DUSA Files Form S-3 Shelf Registration Statement

newsblaze.com
May 16, 2008
        

DUSA Pharmaceuticals, Inc. , a dermatology company that is developing and marketing Levulan photodynamic therapy and other products targeting patients with common skin conditions, today announced the filing of a shelf registration statement with the Secu

DUSA Pharmaceuticals, Inc.: DUSA Files Form S-3 Shelf Registration Statement

marketwire.com
May 16, 2008
        

WILMINGTON, MASSACHUSETTS (MARKET WIRE) DUSA Pharmaceuticals, Inc.(R) (NASDAQ GM: DUSA), a dermatology company that is developing and marketing Levulan(R) photodynamic therapy (PDT) and other products targeting patients with common skin conditions, today announced the filing of a shelf...